Русский

Pharmaceutical Industry Information Portal

News Feed

Drug manufacturers

Ascletis Pharma expands Ritonavir oral tablet production in China

Techno -
Ascletis Pharma Inc. announced the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline...

Angel Yeast Invests in New Enzyme Project Capable of 5,000 Tons Annual Production Output

Techno -
Angel Enzyme Preparation (Yichang) Co., Ltd. is constructing a new green manufacturing project in Angel Biotechnology Industrial Park, Xiaoting...

ROSATOM Successfully Tests Radiopharmaceuticals Production Equipment in Bolivia

Techno -
The highest Center of Nuclear Technology Research and Development in the world by altitude, currently under construction by the...

Regulatory News

Australia has recognized Russia’s Sputnik V COVID-19 vaccine for international travellers

Techno -
International travellers who have had two doses of the Russian Sputnik V vaccine will be permitted to enter Australia...

EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

Techno -
EMA has started evaluating an application for the use of a booster dose of Comirnaty to be given 6...

Falsified COVISHIELD vaccine identified in the WHO regions of Africa and South- East Asia

Techno -
WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products.

World Pharma News

The drug of Uzbek scientists included in the protocol for COVID treatment

Techno -
The “Rutan, 100 mg” drug, developed by scientists of the Institute of Bioorganic Chemistry of the Academy of Sciences...

WHO recommends two new drugs to treat patients with COVID-19

Techno -
The World Health Organization (WHO) reccommended two new drugs to treat patients with COVID-19, one for patients with critical...

U.S. judge bars Martin Shkreli from the pharmaceutical industry, orders $64.6 mln payment

Techno -
A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay...

Don’t miss your daily PharmaProm.Ru news.
SUBSCRIBE free here!

SUBSCRIBE

Expert Articles

WHO Interim Statement on composition of current and future COVID-19 vaccines

Techno -
Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO...

GMP-inspections of veterinary manufacturers in the second half of 2021

Techno -
The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with the requirements of the Good Manufacturing Practice (GMP).

What veterinary medicines manufacturers ask about?

Techno -
On September 22-24, the VI All Russia GMP Conference with international participation, organized by the Ministry of Industry and...

Research and Development

Moderna aims to roll out a combined flu and COVID vaccine in 2023

Techno -
The biotechnological company Moderna is working to create a single shot vaccine against both flu and coronavirus by autumn...

Breakthrough research of UNN chemists to help diabetic patients

Techno -
Federal Service for Intellectual Property (Rospatent) has summed up the results of the year 2021. According to RIA Novosti,...

Gamaleya Center starts testing its anti-COVID medicine based on monoclonal antibodies

Techno -
Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on...

Market analytics

STADA continues to outpace the market in H1 and strengthens basis for further growth

Techno -
STADA again demonstrated its resilience amid challenging conditions due to the pandemic by outperforming industry trends in the first half of 2021.

Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027

Techno -
In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment.

Top biopharma companies could be affected by Brazilian drug patent suspension

Techno -
GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in Russia. It contains a contact base of organizations, enterprises, companies associated with the Russian pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories